申请人:Lee Kwang-Ok
公开号:US20100179120A1
公开(公告)日:2010-07-15
The present invention provides a novel amide derivative and a pharmaceutically acceptable salt thereof which selectively and effectively inhibits the growth of cancer cells induced by the overexpression of an epidermal growth factor receptor and also prevents the development of drug resistance caused by the mutation of EGFR tyrosine kinase, and a pharmaceutical composition comprising same as an active ingredient.
本发明提供了一种新型酰胺衍生物及其药学上可接受的盐,该酰胺衍生物能够选择性和有效地抑制由表皮生长因子受体过度表达引起的癌细胞生长,并且还能够防止由EGFR酪氨酸激酶突变引起的药物耐受性的发展。本发明还提供了一种包含该酰胺衍生物作为活性成分的药物组合物。